Literature DB >> 25734814

The Characterization of Varicella Zoster Virus-Specific T Cells in Skin and Blood during Aging.

Milica Vukmanovic-Stejic1, Daisy Sandhu2, Judith A Seidel3, Neil Patel2, Toni O Sobande3, Elaine Agius2, Sarah E Jackson3, Judilyn Fuentes-Duculan4, Mayte Suárez-Fariñas4, Neil A Mabbott5, Katie E Lacy6, Graham Ogg7, Frank O Nestle6, James G Krueger4, Malcolm H A Rustin8, Arne N Akbar9.   

Abstract

Reactivation of the varicella zoster virus (VZV) increases during aging. Although the effects of VZV reactivation are observed in the skin (shingles), the number and functional capacity of cutaneous VZV-specific T cells have not been investigated. The numbers of circulating IFN-γ-secreting VZV-specific CD4(+) T cells are significantly decreased in old subjects. However, other measures of VZV-specific CD4(+) T cells, including proliferative capacity to VZV antigen stimulation and identification of VZV-specific CD4(+) T cells with an major histocompatibility complex class II tetramer (epitope of IE-63 protein), were similar in both age groups. The majority of T cells in the skin of both age groups expressed CD69, a characteristic of skin-resident T cells. VZV-specific CD4(+) T cells were significantly increased in the skin compared with the blood in young and old subjects, and their function was similar in both age groups. In contrast, the number of Foxp3(+) regulatory T cells and expression of the inhibitory receptor programmed cell death -1 PD-1 on CD4(+) T cells were significantly increased in the skin of older humans. Therefore, VZV-specific CD4(+) T cells in the skin of older individuals are functionally competent. However, their activity may be restricted by multiple inhibitory influences in situ.

Entities:  

Mesh:

Year:  2015        PMID: 25734814      PMCID: PMC4471118          DOI: 10.1038/jid.2015.63

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  58 in total

1.  Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients.

Authors:  Rachael A Clark; Rei Watanabe; Jessica E Teague; Christoph Schlapbach; Marianne C Tawa; Natalie Adams; Andrew A Dorosario; Keri S Chaney; Corey S Cutler; Nicole R Leboeuf; Joi B Carter; David C Fisher; Thomas S Kupper
Journal:  Sci Transl Med       Date:  2012-01-18       Impact factor: 17.956

Review 2.  VZV T cell-mediated immunity.

Authors:  Adriana Weinberg; Myron J Levin
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Different patterns of peripheral migration by memory CD4+ and CD8+ T cells.

Authors:  Thomas Gebhardt; Paul G Whitney; Ali Zaid; Laura K Mackay; Andrew G Brooks; William R Heath; Francis R Carbone; Scott N Mueller
Journal:  Nature       Date:  2011-08-14       Impact factor: 49.962

Review 4.  The immunology of chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection.

Authors:  D Goldblatt
Journal:  J Infect       Date:  1998-01       Impact factor: 6.072

5.  Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.

Authors:  Nicolas Çuburu; Barney S Graham; Christopher B Buck; Rhonda C Kines; Yuk-Ying S Pang; Patricia M Day; Douglas R Lowy; John T Schiller
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

Review 6.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

Review 7.  Memory T cell subsets, migration patterns, and tissue residence.

Authors:  Scott N Mueller; Thomas Gebhardt; Francis R Carbone; William R Heath
Journal:  Annu Rev Immunol       Date:  2012-12-03       Impact factor: 28.527

Review 8.  Skin-resident T cells: the ups and downs of on site immunity.

Authors:  Rachael A Clark
Journal:  J Invest Dermatol       Date:  2009-08-13       Impact factor: 8.551

9.  An expression atlas of human primary cells: inference of gene function from coexpression networks.

Authors:  Neil A Mabbott; J Kenneth Baillie; Helen Brown; Tom C Freeman; David A Hume
Journal:  BMC Genomics       Date:  2013-09-20       Impact factor: 3.969

10.  IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis.

Authors:  Claire Q F Wang; Yemsratch T Akalu; Mayte Suarez-Farinas; Juana Gonzalez; Hiroshi Mitsui; Michelle A Lowes; Seth J Orlow; Prashiela Manga; James G Krueger
Journal:  J Invest Dermatol       Date:  2013-04-30       Impact factor: 8.551

View more
  33 in total

Review 1.  Skin barrier immunity and ageing.

Authors:  Emma S Chambers; Milica Vukmanovic-Stejic
Journal:  Immunology       Date:  2019-12-04       Impact factor: 7.397

Review 2.  Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults.

Authors:  Rawad Elias; Joshua Morales; Carolyn Presley
Journal:  Curr Oncol Rep       Date:  2017-09       Impact factor: 5.075

Review 3.  The Pathobiology of Skin Aging: New Insights into an Old Dilemma.

Authors:  Eleanor Russell-Goldman; George F Murphy
Journal:  Am J Pathol       Date:  2020-04-01       Impact factor: 4.307

Review 4.  Successful and Maladaptive T Cell Aging.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Immunity       Date:  2017-03-21       Impact factor: 31.745

5.  Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.

Authors:  Ryu Watanabe; Tsuyoshi Shirai; Hong Namkoong; Hui Zhang; Gerald J Berry; Barbara B Wallis; Benedikt Schaefgen; David G Harrison; Jennifer A Tremmel; John C Giacomini; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

6.  Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.

Authors:  Adriana Weinberg; Jennifer Canniff; Nadine Rouphael; Aneesh Mehta; Mark Mulligan; Jennifer A Whitaker; Myron J Levin
Journal:  J Immunol       Date:  2017-06-12       Impact factor: 5.422

7.  The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.

Authors:  Adriana Weinberg; Lei Pang; Michael J Johnson; Yupanqui Caldas; Alice Cho; Adriana Tovar-Salazar; Jennifer Canniff; Kenneth E Schmader; Zoran Popmihajlov; Myron J Levin
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

Review 8.  Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?

Authors:  Anne A Gershon
Journal:  J Infect       Date:  2017-06       Impact factor: 6.072

9.  First-line immune checkpoint inhibitors for advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK): a systematic review and network meta-analysis.

Authors:  Tingting Liu; Silu Ding; Jun Dang; Hui Wang; Jun Chen; Guang Li
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

10.  Human natural killer cells mediate adaptive immunity to viral antigens.

Authors:  Rana Nikzad; Laura S Angelo; Kevin Aviles-Padilla; Duy T Le; Vipul K Singh; Lynn Bimler; Milica Vukmanovic-Stejic; Elena Vendrame; Thanmayi Ranganath; Laura Simpson; Nancy L Haigwood; Catherine A Blish; Arne N Akbar; Silke Paust
Journal:  Sci Immunol       Date:  2019-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.